• Home
  • Search Results
  • Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.

Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.

Stem cell research (2013-11-05)
Atsushi Sato, Masashi Okada, Keita Shibuya, Eriko Watanabe, Shizuka Seino, Yoshitaka Narita, Soichiro Shibui, Takamasa Kayama, Chifumi Kitanaka
ABSTRACT

Reactive oxygen species (ROS) are involved in various aspects of cancer cell biology, yet their role in cancer stem cells (CSCs) has been poorly understood. In particular, it still remains unclear whether and how ROS control the self-renewal/differentiation process and the tumor-initiating capacity of CSCs. Here we show that ROS-mediated activation of p38 MAPK plays a pivotal role in the control of differentiation and tumor-initiating capacity of glioma-initiating cells (GICs) derived from human glioblastomas. Mechanistically, ROS triggered p38-dependent Bmi1 protein degradation and FoxO3 activation in GICs, which were shown to be responsible for the loss of their self-renewal capacity and differentiation, respectively. Thus, the results suggest that Bmi1 and FoxO3 govern distinct phases of transition from undifferentiated to fully differentiated cells. Furthermore, we also demonstrate in this study that oxidative stress deprives GICs of their tumor-initiating capacity through the activation of the ROS-p38 axis. As such, this is the first study to the best of our knowledge to delineate how ROS control self-renewal/differentiation and the tumor-initiating capacity of stem-like cancer cells. This study also suggests that targeting of the ROS-p38 axis could be a novel approach in the development of therapeutic strategies against gliomas, represented by glioblastoma.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Acetyl-L-cysteine, suitable for cell culture, BioReagent
Sigma-Aldrich
Cycloheximide, from microbial, ≥94% (TLC)
Sigma-Aldrich
Anti-β-Actin antibody, Mouse monoclonal, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Cycloheximide, ≥95% (HPLC)
Sigma-Aldrich
Cycloheximide solution, Ready-Made Solution, microbial, 100 mg/mL in DMSO, 0.2 μm filtered
Sigma-Aldrich
L-Buthionine-sulfoximine, ≥97% (TLC)
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)
Supelco
Cycloheximide, PESTANAL®, analytical standard
Sigma-Aldrich
SB 203580, solid, ≥98% (HPLC)
Millipore
Cycloheximide solution, 0.1%, suitable for microbiology
Sigma-Aldrich
Cycloheximide, Biotechnology Performance Certified
Sigma-Aldrich
Anti-Nestin antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Bmi-1 Antibody, clone F6, clone F6, Upstate®, from mouse
Sigma-Aldrich
Anti-α-Tubulin Mouse mAb (DM1A), liquid, clone DM1A, Calbiochem®
Sigma-Aldrich
SL327, ≥98% (HPLC), Mixture of E & Z isomers, solid
Sigma-Aldrich
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Musashi-1 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Neurofilament NF-H Antibody, tail domain (Phosphate dependent), clone RMO-24, ascites fluid, clone RMO-24, Chemicon®
Sigma-Aldrich
Monoclonal Anti-MSI1 antibody produced in mouse, clone 3E4, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-MSI1 antibody produced in mouse, clone 4C7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-MSI1 antibody produced in mouse, clone 1C3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-MSI1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-MSI1, (N-terminal) antibody produced in mouse, clone 1B11, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-MSI1, (N-terminal) antibody produced in mouse, clone 3F2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-BMI1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-BMI1 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-PCGF4 antibody produced in mouse, clone 4E10-1C5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Rabbit anti-BMI1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
Sigma-Aldrich
Monoclonal Anti-BMI1 antibody produced in mouse, clone 3E3, ascites fluid

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.